<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404443</article-id>
      <article-id pub-id-type="pmc">2072927</article-id>
      <article-id pub-id-type="publisher-id">9085</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9085-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The role of ATP and adenosine in the brain under normoxic and ischemic conditions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Pedata</surname>
            <given-names>F.</given-names>
          </name>
          <address>
            <phone>+39-55-4271262</phone>
            <fax>+39-55-4271280</fax>
            <email>felicita.pedata@unifi.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Melani</surname>
            <given-names>A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pugliese</surname>
            <given-names>A. M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Coppi</surname>
            <given-names>E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cipriani</surname>
            <given-names>S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Traini</surname>
            <given-names>C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Preclinical and Clinical Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy </aff>
        <aff id="Aff2"><label>2</label>IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>10</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>299</fpage>
      <lpage>310</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>5</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>9</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science+Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>By taking advantage of some recently synthesized compounds that are able to block ecto-ATPase activity, we demonstrated that adenosine triphosphate (ATP) in the hippocampus exerts an inhibitory action independent of its degradation to adenosine. In addition, tonic activation of P2 receptors contributes to the normally recorded excitatory neurotransmission. The role of P2 receptors becomes critical during ischemia when extracellular ATP concentrations increase. Under such conditions, P2 antagonism is protective. Although ATP exerts a detrimental role under ischemia, it also exerts a trophic role in terms of cell division and differentiation. We recently reported that ATP is spontaneously released from human mesenchymal stem cells (hMSCs) in culture. Moreover, it decreases hMSC proliferation rate at early stages of culture. Increased hMSC differentiation could account for an ATP-induced decrease in cell proliferation. ATP as a homeostatic regulator might exert a different effect on cell trophism according to the rate of its efflux and receptor expression during the cell life cycle. During ischemia, adenosine formed by intracellular ATP escapes from cells through the equilibrative transporter. The protective role of adenosine A<sub>1</sub> receptors during ischemia is well accepted. However, the use of selective A<sub>1</sub> agonists is hampered by unwanted peripheral effects, thus attention has been focused on A<sub>2A</sub> and A<sub>3</sub> receptors. The protective effects of A<sub>2A</sub> antagonists in brain ischemia may be largely due to reduced glutamate outflow from neurones and glial cells. Reduced activation of p38 mitogen-activated protein kinases that are involved in neuronal death through transcriptional mechanisms may also contribute to protection by A<sub>2A</sub> antagonism. Evidence that A<sub>3</sub> receptor antagonism may be protective after ischemia is also reported.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Adenosine</kwd>
        <kwd>Adenosine A<sub>2A</sub> receptors</kwd>
        <kwd>ATP</kwd>
        <kwd>Ecto-ATPase inhibitors</kwd>
        <kwd>Ischemia</kwd>
        <kwd>P2 purinergic receptors</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Historical overview</title>
      <p>The physiological roles of adenosine triphosphate (ATP) and its metabolite adenosine have been historically linked to cell metabolism since ATP is an ubiquitous intracellular energy source in a number of enzymatic processes. However, over the years both metabolites have emerged as very versatile molecules of biological systems, being implicated in a variety of cell processes, from platelet aggregation to neurotransmission. The term &#x2018;purinergic signalling&#x2019; was first introduced in the scientific literature by Burnstock [<xref ref-type="bibr" rid="CR1">1</xref>]. An implicit concept for sustaining the hypothesis of purinergic neurotransmission proposed in the 1970s was the existence of purinergic receptors. The first evidence in this direction suggested the existence of two different subfamilies of such &#x2018;purinoceptors&#x2019;, identified as P1 and P2 receptors, selective for adenosine and ATP respectively [<xref ref-type="bibr" rid="CR2">2</xref>]. Four different subtypes of P1-G-protein-coupled receptors: A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub> and A<sub>3</sub> are known at present [<xref ref-type="bibr" rid="CR3">3</xref>], whereas P2 purinoceptors belong to two major families: P2X ligand-gated ion channel receptors and P2Y G-protein-coupled receptors [<xref ref-type="bibr" rid="CR4">4</xref>]. Cloning experiments supported this classification and helped to subdivide P2 receptors into seven P2X and eight P2Y subtypes [<xref ref-type="bibr" rid="CR5">5</xref>] (plus the recently deorphanized GPR17 receptor [<xref ref-type="bibr" rid="CR6">6</xref>]).</p>
    </sec>
    <sec id="Sec2">
      <title>Roles of ATP in neurotransmission under normoxic conditions</title>
      <p>The first studies on the role of extracellular ATP in hippocampal neurotransmission indicated prominent inhibitory action of this purinergic nucleotide on synaptic activity [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. However, several lines of evidence led to the hypothesis that ATP-mediated inhibition of hippocampal neurotransmission was probably mediated by adenosine acting on A<sub>1</sub> receptors. In fact, this response was theophylline-sensitive [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>] and absent in A<sub>1</sub> knockout mice [<xref ref-type="bibr" rid="CR10">10</xref>]. This assumption was supported by the fact that, in the hippocampus, extracellular ATP is rapidly converted into adenosine by ecto-ATPases and ecto-nucleotidases [<xref ref-type="bibr" rid="CR11">11</xref>] and that adenosine acting on A<sub>1</sub> receptors exerts a well-described inhibitory role on CA1 excitatory neurotransmission [<xref ref-type="bibr" rid="CR3">3</xref>]. In recent years, a more detailed observation of ATP-evoked effects, supported by the synthesis of new pharmacological tools, has helped to clarify the effective role of purinergic nucleotides in the hippocampus. In particular, it emerged that ATP mediates inhibitory effects by P2 receptor activation [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>In a recent paper, we contributed to elucidating the role of ATP on CA1 hippocampal neurotransmission, and we reinforced the concept that ATP-mediated effects are not necessarily linked to adenosine formation in this brain region [<xref ref-type="bibr" rid="CR15">15</xref>]. ATP is hydrolysed by ecto-NTPDase, enzymes located on the cell surface in the CNS that limit ATP, ADP and AMP spatio-temporal activity [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. There are three different known NTPDases: NTPDase1 hydrolyzes ATP and ADP equally well, NTPDase2 has a high preference for ATP, NTPDase3 is a functional intermediate, preferably hydrolyzing ATP [<xref ref-type="bibr" rid="CR17">17</xref>]. In our study, we took advantage of some recently synthesized compounds: ARL 67156, which, at micromolar concentrations, inhibits rat NTPDase1 and 3 transiently transfected in Chinese hamster ovary cells, showing negligible activity on NTPDase2 [<xref ref-type="bibr" rid="CR18">18</xref>]; BGO 136, a new inhibitor described as a selective NTPDase1 and 2 blocker with <italic>Ki</italic> values in the high micromolar range [<xref ref-type="bibr" rid="CR19">19</xref>]; and the recently synthesized PV4, which strongly inhibits rat NTPDase1, 2 and 3 with <italic>Ki</italic> values in the nanomolar range [<xref ref-type="bibr" rid="CR20">20</xref>]. By using these inhibitors that are able to block NTPDase activity without interfering with P2 receptor activation, we demonstrated that ATP exerts an inhibitory action, independent of its degradation to adenosine. As shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, the application of ATP during a NTPDase activity blockade still elicits a decrease in evoked synaptic responses which is even more pronounced than that evoked by ATP alone.
<fig id="Fig1"><label>Fig.&#xA0;1a, b</label><caption><p>The inhibitory effect induced by ATP on fEPSP amplitude is potentiated in the presence of different NTPDase inhibitors. <bold>a</bold> Time-course of fEPSP amplitude before, during and after the application of ATP in the absence or in the presence of the NTPDase1,2,3 inhibitor PV4. Each<italic> point</italic> in the graph represents the mean &#xB1; SE of fEPSP value measured as percent of baseline, pre-drug level. <bold>b</bold><italic> Columns</italic> in the graph summarize the average amplitude (mean &#xB1; SE) of evoked fEPSP recorded from CA1 hippocampal region in control conditions, 5 min after superfusion of ATP alone and 5 min after ATP superfusion in the presence of different ecto-ATPases inhibitors. Note that the inhibitory effect of ATP on fEPSP amplitude is potentiated by BGO 136, PV4 and ARL 67156. *<italic>P</italic>&#x2009;&lt;&#x2009;0.05 one-way ANOVA, Newman-Keuls multiple comparison post-hoc test versus pre-drug value. &#xA7;<italic>P</italic>&#x2009;&lt;&#x2009;0.05, one-way ANOVA, Newman-Keuls multiple comparison post-hoc test versus 10&#xA0;&#x3BC;M ATP treated slices. (Modified from [<xref ref-type="bibr" rid="CR15">15</xref>])</p></caption><graphic position="anchor" xlink:href="11302_2007_9085_Fig1_HTML" id="MO1"/></fig></p>
      <p>An excitatory effect of exogenous ATP on hippocampal neurotransmission has also been reported by different authors. This effect, which was observed after drug removal, was described to persist in in vitro preparations for a relatively prolonged period, up to 1&#xA0;h [<xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR25">25</xref>]. This &#x2018;long-lasting&#x2019; potentiation of synaptic responses was compared to electrically evoked LTP, firstly described in the hippocampus by Abrams and Kandel [<xref ref-type="bibr" rid="CR26">26</xref>] and called &#x2018;ATP-induced LTP&#x2019;. In agreement, we observed a potentiation of the synaptic responses after drug removal when slices were superfused in the presence of the metabolically stable ATP-analogue ATP&#x3B3;S (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition to this &#x2018;long-lasting&#x2019; excitatory effect evoked by the exogenous application of P2 agonists, we also demonstrated an excitatory tone exerted by endogenous ATP. Slices superfused with P2 antagonists show a small but significant reduction in synaptic transmission (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). These data demonstrate that tonic activation of P2 receptors contributes to glutamatergic excitatory neurotransmission in the hippocampus, an observation that is in line with previous work [<xref ref-type="bibr" rid="CR27">27</xref>].
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Inhibitory and excitatory effects of the stable ATP analogue ATP&#x3B3;S. Averaged time-course (<italic>n</italic>&#x2009;=&#x2009;4) of PS amplitude before, during and after the application of different concentrations of ATP&#x3B3;S. PS amplitude (mean &#xB1; SE) is measured as percent of baseline level.<italic> Upper panels</italic> represent single traces recorded in a typical experiment before, during and after ATP&#x3B3;S application at different concentrations</p></caption><graphic position="anchor" xlink:href="11302_2007_9085_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Excitatory effects of endogenous ATP.<italic> Bars</italic> in the graphs represent the average of fEPSP amplitude in the presence of P2 antagonists: PPADS (30 &#x3BC;M) and MRS 2179 (10&#xA0;&#x3BC;M). *<italic>P</italic>&#x2009;&lt;&#x2009;0.05, paired Student&#x2019;s<italic> t</italic>-test. (Modified from [<xref ref-type="bibr" rid="CR15">15</xref>])</p></caption><graphic position="anchor" xlink:href="11302_2007_9085_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec3">
      <title>Roles of ATP in ischemic conditions</title>
      <p>The role of ATP may become critical during pathological conditions such as ischemia, when extracellular ATP concentrations increase. An enhanced outflow of radioactive ATP from hippocampal slices during in vitro ischemic-like insults was first reported by Juranyi and co-workers [<xref ref-type="bibr" rid="CR28">28</xref>], and the first demonstration that ATP outflow increases in vivo during the induction of focal ischemia in the rat was reported by Melani and colleagues [<xref ref-type="bibr" rid="CR29">29</xref>]. Thus, at the ischemic site, levels of extracellular nucleotides may remain elevated for long periods of time after injury. Evidence supports the idea that, under such pathological conditions, released ATP may exert an excitotoxic role by acting on its receptors, thus enhancing Ca<sup>2+</sup> inward currents and altering synaptic activity and cellular plasticity. Non-selective antagonists of P2 receptors, suramin and PPADS, and the selective antagonists, BBG and MRS 2179 of P2X<sub>7</sub> and P2Y<sub>1</sub> receptors respectively, prevent the irreversible failure of neurotransmission induced by a prolonged period of OGD in hippocampal slices [<xref ref-type="bibr" rid="CR15">15</xref>]. Moreover, they protect from development of anoxic depolarization (AD), which is a rapid and regenerative wave of depolarization that propagates in tissue and represents an unequivocal sign of sufferance [<xref ref-type="bibr" rid="CR15">15</xref>]. Antagonists of P2 receptors have been proved protective against cell death induced by either ATP itself, hypoglycemia or glutamate exposure in primary cultures of brain-derived neurones [<xref ref-type="bibr" rid="CR30">30</xref>&#x2013;<xref ref-type="bibr" rid="CR33">33</xref>]. Intrastriatal ATP injection in rats induced, 24&#xA0;h later, a clearly lesioned area [<xref ref-type="bibr" rid="CR34">34</xref>]. The ATP-induced damage was concentration-dependent, mimicked by ATP&#x3B3;S and &#x3B1;,&#x3B2; meATP (but not by ADP or adenosine) and blocked by RB2, a non-specific P2 antagonist [<xref ref-type="bibr" rid="CR34">34</xref>]. Suramin, another non-specific P2 receptor antagonist, administered 30&#xA0;min before occlusion of the middle cerebral artery, resulted in a significant decrease in infarct and oedema volume 6&#xA0;h after brain injury [<xref ref-type="bibr" rid="CR35">35</xref>]. In agreement, it was demonstrated that RB2 [<xref ref-type="bibr" rid="CR36">36</xref>] and PPADS [<xref ref-type="bibr" rid="CR37">37</xref>] improve neurological deficit and reduce the damage induced in rats in a model of focal ischemia in vivo. Moreover, RB2 induces the expression of P2X<sub>7</sub> receptors on reactive microglia in the remote ipsi and contralateral cingulate and medial frontal cortex and striatum. Although a pro-apoptotic role has been attributed to the P2X<sub>7</sub> receptor, results suggest that microglial cells expressing the P2X<sub>7</sub> receptor can be implicated in tissue damage as well as in the defence and repairing processes in the remote ipsi and contralateral undamaged areas [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
      <p>In considering the effect of ATP during ischemia, it must be taken into account that ATP itself is involved in control of cerebrovascular regulation [<xref ref-type="bibr" rid="CR38">38</xref>] and that the metabolite of ATP, ADP, that interacts with P2Y<sub>1</sub>/P2Y<sub>12</sub> receptors, is a potent platelet aggregator. However, clinical studies that checked the antiplatelet therapy of the selective P2Y<sub>12</sub> receptor antagonist clopidogrel reported a response variability [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>].</p>
      <p>Although evidence suggests that ATP exerts a detrimental role under ischemia, there are reports that it may exert a trophic role in terms of cell division and differentiation in both differentiated and undifferentiated cells [<xref ref-type="bibr" rid="CR41">41</xref>&#x2013;<xref ref-type="bibr" rid="CR43">43</xref>], including adult neural stem cells [<xref ref-type="bibr" rid="CR44">44</xref>]. Interesting data correlate these trophic effects with the occurrence of spontaneous Ca<sup>2+</sup> waves that propagate among adjacent cells in a self-renewing manner. Kawano et al. [<xref ref-type="bibr" rid="CR45">45</xref>] reported that ATP-induced initiation and propagation of intracellular Ca<sup>2+</sup> waves in human mesenchymal stem cells (hMSCs) promote activation of transcription factors (e.g. NFAT) that are involved in cell differentiation. In the same study, they demonstrated that ATP-induced Ca<sup>2+</sup> waves disappear in the fully differentiated adipogenic phenotype. We recently reported that ATP is spontaneously released from hMSCs during the early stages of culture (P0-P5). Moreover, we reported that ATP decreases proliferation rate (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) and modulates specific ionic current hMSCs [<xref ref-type="bibr" rid="CR46">46</xref>]. A high extracellular ATP concentration at earlier cell culture passages suggests an important role of ATP in regulating cell differentiation. Increased hMSC differentiation may account for an ATP-induced decrease in cell proliferation.
<fig id="Fig4"><label>Fig.&#xA0;4a, b</label><caption><p>Human mesenchymal stem cells in culture spontaneously release ATP that modulates cell proliferation. <bold>a</bold> Extracellular concentrations of ATP were measured in the medium containing hMSCs and in control medium not containing cells. Data are expressed as mean &#xB1; SE, <italic>n</italic>&#x2009;=&#x2009;11, unpaired Student&#x2019;s <italic>t</italic>-test: *<italic>P</italic>&#x2009;&lt;&#x2009;0.0001 vs medium alone. <bold>b</bold> Effect on hMSC proliferation after daily application of ATP (10&#xA0;&#x3BC;M) and P2 antagonists, PPADS (30&#xA0;&#x3BC;M) and MRS 2179 (10&#xA0;&#x3BC;M). Data are expressed as percentage of proliferation. Proliferation of untreated cells was assumed as 100%. The cell number was determined after 5&#xA0;days of culture by a culture counter. Each<italic> column bar</italic> represents the mean &#xB1; SE of <italic>n</italic>&#x2009;=&#x2009;4 for each experimental condition. Paired Student&#x2019;s <italic>t</italic>-test: *<italic>P</italic>&#x2009;&lt;&#x2009;0.05 vs respective control; one-way ANOVA, Newman-Keuls post-test: &#xA7;<italic>P</italic>&#x2009;&lt;&#x2009;0.05 vs 10&#xA0;&#x3BC;M ATP-treated cells. (Modified from [<xref ref-type="bibr" rid="CR46">46</xref>])</p></caption><graphic position="anchor" xlink:href="11302_2007_9085_Fig4_HTML" id="MO4"/></fig></p>
      <p>Therefore, it can be envisaged that ATP, as an autocrine/paracrine homeostatic regulator, exerts different effects on cell trophism according to its extracellular concentrations, distinct cell populations involved, differential expression and recruitment of P2 receptors and of more or less sustained stimulation of the same receptor. Balancing these effects may be relevant in the post-ischemic brain, when a neuroregenerative process could promote tissue repair [<xref ref-type="bibr" rid="CR47">47</xref>]. On this basis, determination of ATP extracellular concentrations at various times after ischemia induction may help to identify which types of receptors may be stimulated under ischemia and explain the role of detrimental versus trophic ATP during ischemia. ATP present in the extracellular space is rapidly metabolised by membrane-bound NTPDase. Extracellular ATP concentrations, evaluated in the brain to date, have been underestimated, since it has not been possible to selectively inhibit ecto-NTPDase. In fact, the selective inhibitor ARL 67156, tentatively used thus far to inhibit ecto-NTPDase, interferes with the ATP assay method [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
    </sec>
    <sec id="Sec4">
      <title>Role of adenosine in cerebral transmission under normoxic conditions</title>
      <p>Adenosine exerts an important tonic modulation of synaptic transmission in the brain. This tonic inhibition of synaptic transmission is evoked by stimulation of A<sub>1</sub> receptors, as demonstrated in several brain regions, such as the hippocampus, striatum and olfactory cortex [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The inhibitory effect of adenosine A<sub>1</sub> receptor stimulation has a pre- and postsynaptic component. Activation of the presynaptic A<sub>1</sub> receptors reduces Ca<sup>2+</sup> influx through the preferential inhibition of N-type and, probably, Q-type channels [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. Inhibition of presynaptic calcium currents decreases transmitter release [<xref ref-type="bibr" rid="CR52">52</xref>], and adenosine, by stimulation of A<sub>1</sub> receptors, has been found to inhibit the release of virtually all classical neurotransmitters: glutamate, acetylcholine, dopamine, noradrenaline and serotonin (see in [<xref ref-type="bibr" rid="CR53">53</xref>]). In particular, powerful suppression of glutamate release from presynaptic terminals has been described in the hippocampus [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], where adenosine A<sub>1</sub> receptor activation reduces the number of quanta released (but not the size of individual quanta nor postsynaptic glutamate receptor sensitivity) in the Schaffer collateral-commissural pathway [<xref ref-type="bibr" rid="CR56">56</xref>]. The postsynaptic effect of A<sub>1</sub> receptors consists of direct hyperpolarisation of neurones via activation of GIRK channels (Kir 3.2 and 3.4 channels: potassium inward rectifiers) [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Endogenous adenosine exerts tonic inhibition of excitatory neurotransmission. The selective A<sub>1</sub> antagonist, DPCPX, causes a 15% increase in synaptic potential amplitude in in vitro brain slices [<xref ref-type="bibr" rid="CR59">59</xref>]. This is an expected result in a brain region where the adenosine concentration at a receptor level was calculated around 200&#xA0;nM [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] and A<sub>1</sub> receptors, whose affinity for adenosine is in the low nanomolar range, are highly expressed. These data are confirmed by the fact that, in slices taken from homozygous A<sub>1</sub> receptor knockout mice, no evidence was found for an endogenous inhibitory action by adenosine in the Schaffer collateral pathway in the CA1 region of the hippocampus or at the mossy fibre synapses in the CA3 region [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
      <p>Opposite effects from A<sub>1</sub>-mediated synaptic inhibition are elicited by A<sub>2A</sub> receptor activation, which has been shown to mediate excitatory actions in synaptic function [<xref ref-type="bibr" rid="CR62">62</xref>&#x2013;<xref ref-type="bibr" rid="CR64">64</xref>]. In the hippocampus in vitro, A<sub>2A</sub> receptor stimulation results in a Ca<sup>2+</sup>-dependent release of acetylcholine [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Furthermore, the application of CGS 21680, a selective A<sub>2A</sub> receptor agonist, decreases the ability of A<sub>1</sub> receptor agonists to inhibit excitatory neurotransmission [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. This effect suggests that A<sub>2A</sub> receptor stimulation increases synaptic transmission through A<sub>1</sub> receptor desensitisation [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. However, there is also evidence that A<sub>2A</sub> receptors increase excitatory amino acid release. In fact, the selective stimulation of adenosine A<sub>2A</sub> receptors augments the amount of glutamate released in the hippocampus and striatum of young rats [<xref ref-type="bibr" rid="CR70">70</xref>&#x2013;<xref ref-type="bibr" rid="CR72">72</xref>].</p>
      <p>In spite of the excitatory role in neurotransmission brought about by A<sub>2A</sub> receptors, the net effect of adenosine is an inhibitory tonus on neurotransmission, in accordance with observations suggesting that activation of A<sub>2A</sub> receptors requires protracted stimulation to induce evident effects on synaptic transmission [<xref ref-type="bibr" rid="CR59">59</xref>]. It is worth noticing that the role of A<sub>2A</sub> receptors in the striatum is recently gaining interest in light of their heterodimerisation with D<sub>2</sub> dopamine receptors. The association between A<sub>2A</sub> and D<sub>2</sub> receptors results in an antagonistic interaction that provides a rationale for evaluating A<sub>2A</sub>-selective antagonists in Parkinson&#x2019;s disease, supported by epidemiological evidence indicating an inverse relationship between caffeine consumption and the risk of developing this pathology [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. It was suggested that A<sub>2A</sub> antagonists not only provide symptomatic relief but also decelerate dopaminergic neurone degeneration in patients.</p>
      <p>Discrepancies about the role of adenosine A<sub>3</sub> receptors in the brain are present in the literature. Activation of this receptor subtype has been associated with both excitatory and inhibitory effects, even in the same brain region. An excitatory role of A<sub>3</sub> receptors has been supported by evidence indicating that, in the rat hippocampus, their activation attenuates LTD and allows induction of LTP elicited by a subliminal weak-burst protocol [<xref ref-type="bibr" rid="CR75">75</xref>]. In addition, in the same brain area, A<sub>3</sub> receptor activation through a selective adenosine A<sub>3</sub> agonist has been shown to antagonize the adenosine A<sub>1</sub> receptor-mediated inhibition of excitatory neurotransmission [<xref ref-type="bibr" rid="CR8">8</xref>]. Moreover, A<sub>3</sub> receptor stimulation always attenuates the inhibition of hippocampal slice neurotransmission, in a PKC-dependent manner, caused by presynaptic metabotropic glutamate receptors [<xref ref-type="bibr" rid="CR76">76</xref>]. Whole-cell patch clamp recordings in CA3 hippocampal pyramidal neurones demonstrate that A<sub>3</sub> receptor activation results in a significant potentiation of high threshold hippocampal Ca<sup>2+</sup> currents by a PKA-dependent mechanism [<xref ref-type="bibr" rid="CR77">77</xref>]. Finally, facilitation of the onset of epileptiform discharge has been observed in the presence of the selective A<sub>3</sub> receptor agonist Cl-IB-MECA [<xref ref-type="bibr" rid="CR78">78</xref>], and a reduction in such epileptic activity was observed when A<sub>3</sub> receptors, activated by endogenously released adenosine during seizures, were blocked by the selective antagonist MRS 1191 [<xref ref-type="bibr" rid="CR79">79</xref>].</p>
      <p>Contrary to previous results, an inhibitory action has been attributed to A<sub>3</sub> receptors by Brand and colleagues [<xref ref-type="bibr" rid="CR80">80</xref>], who demonstrated that, in rat cortical neurones, the selective activation of this adenosine receptor subtype is involved in inhibition of excitatory neurotransmission, suggesting a synergistic action with the inhibitory effect of adenosine brought about by A<sub>1</sub> receptor activation. Despite results obtained by A<sub>3</sub> receptor stimulation, evidence that a selective block of A<sub>3</sub> receptors does not affect neurotransmission in the CA1 region of the hippocampus under normoxic conditions indicates that endogenous adenosine at physiological concentrations does not exert tonic activation of A<sub>3</sub> receptors [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. This is in line with evidence that A<sub>3</sub> receptor activation requires micromolar levels of extracellular adenosine, which can be reached only during pathological conditions of impairment in energy supply (for example during hypoxia or ischemia [<xref ref-type="bibr" rid="CR82">82</xref>&#x2013;<xref ref-type="bibr" rid="CR85">85</xref>]).</p>
    </sec>
    <sec id="Sec5">
      <title>Role of adenosine in ischemic conditions</title>
      <p>Extracellular adenosine concentrations increase dramatically during ischemia [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. During ischemia, following the imbalance between ATP degradation and resynthesis, the intracellular concentration of adenosine increases. Therefore, increased adenosine concentrations in the extracellular space during ischemia are likely due to the equilibrative transporter that carries adenosine out of cells. Adenosine formation can also take place at the extracellular level, through the hydrolysis of extracellular ATP operated by NTPDases and ecto-5&#x2032;-nucleotidase (e5&#x2032;-NTs) (see Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). Hence, these enzymes have a dual function in modulating purinergic neurotransmission: (1) they rapidly interrupt ATP-mediated signalling by degrading extracellular nucleotides and (2) they give rise to extracellular adenosine, which activates P1 receptors. However, recent evidence in vitro suggests that released ATP does not substantially contribute to the adenosine concentration in the extracellular milieu during ischemia [<xref ref-type="bibr" rid="CR88">88</xref>].
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Schematic drawing of intracellular and extracellular adenosine formation. In the extracellular space, adenosine and ATP act on own purinergic receptor subtypes: P1 and P2 receptors, respectively.<italic> ADP</italic> adenosine diphosphate,<italic> AMP</italic> adenosine monophosphate,<italic> ATP</italic> adenosine triphosphate,<italic> e5&#x2032;-NT</italic> ecto-5&#x2032;-nucleotidase, <italic>5&#x2032;-NT</italic> 5&#x2032;-nucleotidase,<italic> NTDPase</italic> ecto-nucleoside triphosphate diphosphohydrolases,<italic> P1</italic> adenosine receptor,<italic> P2</italic> ATP receptor,<italic> SAH</italic> S-adenosylhomocysteine,<italic> T</italic> bidirectional nucleoside transporter. (Modified from [<xref ref-type="bibr" rid="CR142">142</xref>])</p></caption><graphic position="anchor" xlink:href="11302_2007_9085_Fig5_HTML" id="MO5"/></fig></p>
      <p>Adenosine-potentiating agents, which elevate endogenous adenosine levels by either inhibiting its metabolism by adenosine deaminase or kinase [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>] or preventing its transport [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], offer protection against ischemic neuronal damage in different in vivo ischemia models. Moreover, adenosine infusion into the ischemic striatum during transient focal ischemia proves to significantly ameliorate the neurological outcome and reduce infarct volume [<xref ref-type="bibr" rid="CR93">93</xref>].</p>
      <p>A temporal correlation exists between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. Synaptic inhibition during ischemia is greatly dependent on adenosine, which, by stimulating A<sub>1</sub> receptors, exerts a protective role by reducing the Ca<sup>2+</sup> influx, thus counteracting the presynaptic release of excitatory neurotransmitters [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR94">94</xref>] and, in particular, glutamate, which exerts an excitotoxic role during ischemia mainly by overstimulation of NMDA receptors [<xref ref-type="bibr" rid="CR95">95</xref>]. By directly increasing the K<sup>+</sup> and Cl<sup>&#x2212;</sup> ion conductances, adenosine stabilises the neuronal membrane potentials, thus reducing neuronal excitability [<xref ref-type="bibr" rid="CR96">96</xref>]. Consequent reductions in cellular metabolism and energy consumption [<xref ref-type="bibr" rid="CR97">97</xref>] and moderate lowering of the body/brain temperature [<xref ref-type="bibr" rid="CR98">98</xref>] are protective in ischemia.</p>
      <p>A<sub>1</sub> receptor agonists are shown to attenuate ischemic or excitotoxic neuronal damage in both in vitro and in vivo models of cerebral ischemia (for review, see [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]). In accordance, adenosine A<sub>1</sub> antagonists given acutely exacerbate the damage induced by ischemia in different animal models of ischemia. An unselective A<sub>1</sub> receptor antagonist, theophylline, increased mortality [<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Unlike acute treatment, chronic administration of A<sub>1</sub> agonists worsened survival and increased neuronal loss [<xref ref-type="bibr" rid="CR103">103</xref>], a phenomenon thought to depend on A<sub>1</sub> receptor desensitization.</p>
      <p>Although data converge in demonstrating a neuroprotective effect of adenosine through A<sub>1</sub> receptors during ischemia, the use of selective A<sub>1</sub> agonists is hampered by unwanted peripheral effects, e.g. sedation, bradycardia, hypotension [<xref ref-type="bibr" rid="CR104">104</xref>]. Von Lubitz and co-workers [<xref ref-type="bibr" rid="CR105">105</xref>] have reported that post-ischemic administration of the A<sub>1</sub> receptor agonist adenosine amine congener (ADAC), which induces fewer undesirable effects, increases survival in gerbils. Moreover, we may consider that administration of agents that elevate the local concentration of adenosine at the injury site, by inhibiting its metabolism to inosine or rephosphorylation to AMP or reuptake, may have the advantage of restricting the effect of such inhibitors to areas of injury-induced adenosine release [<xref ref-type="bibr" rid="CR106">106</xref>].</p>
      <p>More recently, the role of A<sub>2A</sub> receptors in ischemic neuroprotection has been studied. Gao and Phillis [<xref ref-type="bibr" rid="CR107">107</xref>] demonstrated for the first time that the non-selective A<sub>2A</sub> receptor antagonist CGS 15943 reduces cerebral ischemic injury in the gerbil following global forebrain ischemia. Subsequently, many reports have confirmed the neuroprotective role of A<sub>2A</sub> receptor antagonists in different models of ischemia. The selective A<sub>2A</sub> receptor antagonist SCH 58261 reduced ischemic brain damage in neonatal [<xref ref-type="bibr" rid="CR108">108</xref>] and adult [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR109">109</xref>] rat models of focal cerebral ischaemia. The same antagonist, subchronically administered, was protective against both brain damage and neurological deficit in the adult rat model of focal cerebral ischemia [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]. Studies in A<sub>2A</sub> receptor knockout mice supported the neuroprotective role of A<sub>2A</sub> receptor antagonists on ischemic brain damage [<xref ref-type="bibr" rid="CR112">112</xref>]. The beneficial effects of A<sub>2A</sub> antagonists in stroke were mainly attributed to reduced glutamate outflow [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]. Prolonged application of the A<sub>2A </sub>selective agonist CGS 21680 significantly reduced synaptic depression brought about by OGD in the hippocampus [<xref ref-type="bibr" rid="CR59">59</xref>] and the same agonist promotes glutamate release under normoxic and ischemic conditions [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. In addition to neurones, adenosine A<sub>2A</sub> receptors are located on microglia [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>] and astrocytes [<xref ref-type="bibr" rid="CR118">118</xref>]. On glial cells, A<sub>2A</sub> receptors mediate inhibition of the glutamate uptake transporter, GLT-1, and stimulate glutamate outflow [<xref ref-type="bibr" rid="CR119">119</xref>]. A<sub>2A</sub> antagonists prevent the increase in glutamate levels induced by glutamate uptake inhibitors [<xref ref-type="bibr" rid="CR120">120</xref>]. Therefore, the protective effects of A<sub>2A</sub> antagonists in brain ischemia may be largely due to reduced glutamate outflow from neurones and glial cells.</p>
      <p>Further support of a major role for glia in the neuroprotective effect of A<sub>2A</sub> antagonism in ischemia comes from the observation that subchronic administration of the A<sub>2A</sub> receptor antagonist SCH 58261 reduces p38 mitogen-activated protein kinase (MAPK) activation in striatal and cortical microglia 24&#xA0;h after permanent focal ischemia [<xref ref-type="bibr" rid="CR111">111</xref>]. Evidence indicates that p38 MAPK is activated in glia up to 24&#xA0;h after ischemia [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>] and is involved, through transcriptional mechanisms, in neuronal death [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. Since SCH 58261 reduces glutamate outflow in the first hours after ischemia [<xref ref-type="bibr" rid="CR83">83</xref>], reduced p38 MAPK activation may be due to a direct effect on glial A<sub>2A</sub> receptors or may be secondary to a reduction in the excitotoxic cascade that primes p38 activation [<xref ref-type="bibr" rid="CR125">125</xref>]. The importance of A<sub>2A</sub> receptors under ischemia is highlighted by the observation that A<sub>2A</sub> receptor expression increases on neurones and microglia after ischemia [<xref ref-type="bibr" rid="CR126">126</xref>]. Selective inactivation of A<sub>2A</sub> receptors on bone-marrow-derived cells (wild-type mice transplanted with A<sub>2A</sub> receptor knockout bone marrow cells) attenuates infarct volumes and ischemia-induced expression of several proinflammatory cytokines in the brain [<xref ref-type="bibr" rid="CR127">127</xref>]. Therefore, protective effects of A<sub>2A</sub> antagonists may be attributed to inhibition of inflammation product production.</p>
      <p>In several studies, A<sub>2A</sub> receptor agonists have been found to be protective in the global ischemia model in the gerbil [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]. Jones and co-workers [<xref ref-type="bibr" rid="CR130">130</xref>] show that peripheral administration of the A<sub>2A</sub> receptor agonist CGS 21680 protects the hippocampus against kainate-induced excitotoxicity. However, the direct injection of CGS 21680 into the hippocampus failed to afford protection, while the A<sub>2A</sub> antagonist ZM 241385, when injected directly into the hippocampus, reduced kainate-induced neuronal damage [<xref ref-type="bibr" rid="CR131">131</xref>]. These data suggest that the neuroprotective properties of A<sub>2A</sub> agonists are mainly due to peripherally mediated effects. Major mechanisms that may account for A<sub>2A</sub>-mediated protection include inhibition of platelet aggregation and vasodilation [<xref ref-type="bibr" rid="CR89">89</xref>] and anti-inflammatory actions. A<sub>2A</sub> receptors on neutrophils may account for inhibition of adhesion to endothelial cells and ensuing production of free radicals [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR133">133</xref>].</p>
      <p>On this basis, adenosine and its receptors are considered targets for therapeutic implementation in the treatment of stroke. At the moment, a possible adenosynergic therapeutic strategy after ischaemia that is worth consideration is that of increasing adenosine concentrations at the ischemic sites by inhibitors of adenosine metabolism or reuptake in association with adenosine A<sub>2A</sub> antagonists. When considering the possible use of adenosine kinase inhibitors, it should be taken into account that adenosine represents only a small percentage of nucleotide content [<xref ref-type="bibr" rid="CR134">134</xref>], therefore inhibition of its rephosphorylation to ATP by adenosine kinase inhibitors does not weigh upon the ATP content.</p>
      <p>The few studies present in the literature concerning the role of A<sub>3</sub> receptors in the pathophysiology of cerebral ischemia are rather contradictory. We have demonstrated that selective antagonism of A<sub>3</sub> receptors facilitates the recovery of synaptic activity induced by ischemic preconditioning in rat hippocampal slices [<xref ref-type="bibr" rid="CR81">81</xref>]. A harmful role of A<sub>3</sub> receptors during in vitro OGD was confirmed by our observation that blocking the A<sub>3</sub> adenosine receptor consistently abolishes or delays the occurrence of anoxic depolarization (AD) and significantly protects from the irreversible disruption of excitatory neurotransmission caused by a severe ischemic episode [<xref ref-type="bibr" rid="CR135">135</xref>]. These results are in agreement with the observation that acute administration of a selective adenosine A<sub>3</sub> agonist exacerbates the damage elicited by global ischemia in the gerbil [<xref ref-type="bibr" rid="CR136">136</xref>]. On the contrary, it was demonstrated that chronic pre-ischemic administration of an A<sub>3</sub> agonist protects against ischemic neuronal damage [<xref ref-type="bibr" rid="CR136">136</xref>]. This effect may be attributed to desensitisation of A<sub>3</sub> receptors. In fact, both human and rat A<sub>3</sub> receptors are desensitised within a few minutes after agonist exposure [<xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR138">138</xref>].</p>
      <p>Contrary to the above information, Hentschel and colleagues [<xref ref-type="bibr" rid="CR139">139</xref>] demonstrated that under hypoxic conditions, selective activation of A<sub>3</sub> adenosine receptors brings about an inhibition of excitatory neurotransmission on cortical neurones, indicating that A<sub>3</sub> receptors may sustain the neuroprotective action of adenosine induced by A<sub>1</sub> receptors. Consistent with these reports, mice lacking A<sub>3</sub> adenosine receptors show increased neurodegeneration in response to repeated episodes of moderate hypoxia [<xref ref-type="bibr" rid="CR140">140</xref>] or an increase in cerebral infarction after transient ligation of the middle cerebral artery [<xref ref-type="bibr" rid="CR141">141</xref>]. These opposite results regarding an excitatory or inhibitory role of A<sub>3</sub> receptors on synaptic activity under hypoxia/ischemia may be reconciled by our recent data [<xref ref-type="bibr" rid="CR135">135</xref>], suggesting that in a first phase of ischemia, A<sub>3</sub> receptors play a protective synergistic role with A<sub>1</sub> receptors. Severe ischemia would transform the A<sub>3</sub> receptor-mediated effects from protective to injurious.</p>
      <p>Taken together, these data suggest that the outcome of A<sub>3</sub> receptor stimulation on synaptic transmission during hypoxic/ischemic phenomena depends on the intensity and duration of stimulation.</p>
    </sec>
    <sec id="Sec6">
      <title>Concluding remarks</title>
      <p>Purinergic signalling, e.g. adenosine and ATP, by activating specific membrane receptors (P1 and P2 respectively), is strictly correlated in orchestrating brain cell functions either under physiological normoxic or ischemic circumstances. However, the respective contribution of each single element is hard to discern from the total outcome, due to the rapid and ubiquitous enzymatic interconversion of these molecules.</p>
      <p>In the brain, both compounds are likely to play a role in neuronal activity, and the inhibitory action of endogenous adenosine in excitatory neurotransmission (mainly due to A<sub>1</sub> receptor activation) is well documented. Conversely our data, in line with previous observations in the literature, suggest that tonic activation of P2 receptors contributes to excitatory transmission in the hippocampus. Such an effect is modest, but it is unmasked by the application of P2 purinergic antagonists that reduce evoked synaptic responses.</p>
      <p>An inhibitory effect elicited by exogenous ATP application has been frequently described and is mostly due to enzymatic degradation to adenosine and the subsequent activation of A<sub>1</sub> receptors. However, our evidence demonstrates that ATP itself may inhibit hippocampal synaptic transmission since an even more pronounced effect is observed when enzymatic ATP degradation is blocked. Moreover, in our studies in the hippocampus, a potentiation of neurotransmission by the ATP analogue, ATP&#x3B3;S, develops a few minutes after the inhibitory effect has been washed out, and it persists for 45&#xA0;min to 1&#xA0;h. Within the brain, ATP is involved in the synaptic plasticity phenomenon and may be an important mediator of long-lasting effects in synaptic plasticity.</p>
      <p>Either adenosine or ATP seems to become a particularly important signalling molecule under pathological conditions, such as ischemia, when the extracellular concentration of either compound drastically rises. It is well known that adenosine exerts important neuroprotective effects during brain ischemic insults by activating adenosine A<sub>1</sub> receptors, which profoundly inhibit synaptic transmission and in particular the release of glutamate, known to contribute to ischemic damage. Under severe ischemia, a prolonged stimulation of both A<sub>2A</sub> and A<sub>3</sub> receptors may be deleterious. The role of endogenously released ATP during cerebral ischemia is mainly deleterious, as found in our work and in the literature, since the application of P2 antagonists always results in a reduction in ischemic damage. The mechanisms underlying these effects are still unknown, but they can be correlated to the tonic excitatory action of endogenous ATP found in many brain regions (for example in the hippocampus and prefrontal cortex).</p>
      <p>Purinergic signalling has an ancient phylogenetic origin. Expression of P2 receptors on cell membrane and responses to extracellular ATP are found in primitive prokaryotic species up to evolved animals and plants, suggesting an important and highly conserved role of extracellular purine nucleotides during evolution. Similarly, ontogenetic development in several species seems to involve purinergic signalling, especially during its first stages. Our observation that hMSCs, an undifferentiated line of cells able to originate a number of different cell lineages (adipocytes, chondrocytes, osteoblasts, neurones), spontaneously release ATP into the extracellular space and express functional purinergic P2 receptors, which modulate different kinds of membrane currents, and that ATP, during the early stages of culture, inhibits proliferation indicates an autocrine/paracrine mechanism of action for extracellular ATP in modulating cell functions of undifferentiated stem cells at early developmental stages. Such effects may be important in brain neurogenesis during development and in responses to neurodegenerative stimuli.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The present work was supported by Fondazione Monte dei Paschi of Siena, Siena, Italy.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dumsday</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Smythe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide</article-title>
          <source>Br J Pharmacol</source>
          <year>1972</year>
          <volume>44</volume>
          <fpage>451</fpage>
          <lpage>461</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G, Dumsday B, Smythe A (1972) Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol 44:451&#x2013;461 <pub-id pub-id-type="pmid">4339250</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cocks</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasakov</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Direct evidence for ATP release from non-adrenergic, non-cholinergic (&#x201C;purinergic&#x201D;) nerves in the guinea-pig taenia coli and bladder</article-title>
          <source>Eur J Pharmacol</source>
          <year>1978</year>
          <volume>49</volume>
          <fpage>145</fpage>
          <lpage>149</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G, Cocks T, Kasakov L et al (1978) Direct evidence for ATP release from non-adrenergic, non-cholinergic (&#x201C;purinergic&#x201D;) nerves in the guinea-pig taenia coli and bladder. Eur J Pharmacol 49:145&#x2013;149 <pub-id pub-id-type="pmid">658131</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>IJzerman</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors</article-title>
          <source>Pharmacol Rev</source>
          <year>2001</year>
          <volume>53</volume>
          <fpage>527</fpage>
          <lpage>552</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fredholm BB, IJzerman AP, Jacobson KA et al (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527&#x2013;552 <pub-id pub-id-type="pmid">11734617</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbracchio</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Purinoceptors: are there families of P2X and P2Y purinoceptors?</article-title>
          <source>Pharmacol Ther</source>
          <year>1994</year>
          <volume>64</volume>
          <fpage>445</fpage>
          <lpage>475</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445&#x2013;475 <pub-id pub-id-type="pmid">7724657</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Molecular physiology of P2X receptors</article-title>
          <source>Physiol Rev</source>
          <year>2002</year>
          <volume>82</volume>
          <fpage>1013</fpage>
          <lpage>1067</lpage>
        </citation>
        <citation citation-type="display-unstructured">North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013&#x2013;1067 <pub-id pub-id-type="pmid">12270951</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fumagalli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trincavelli</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor</article-title>
          <source>EMBO J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>4615</fpage>
          <lpage>4627</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ciana P, Fumagalli M, Trincavelli ML et al (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25:4615&#x2013;4627 <pub-id pub-id-type="pmid">16990797</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>1987</fpage>
          <lpage>1995</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Sebastiao AM, Ribeiro JA (1998) Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci 18:1987&#x2013;1995 <pub-id pub-id-type="pmid">9482785</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Diao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Proctor</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>7673</fpage>
          <lpage>7682</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dunwiddie TV, Diao L, Proctor WR (1997) Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17:7673&#x2013;7682 <pub-id pub-id-type="pmid">9315889</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Kane</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro</article-title>
          <source>Eur J Pharmacol</source>
          <year>1998</year>
          <volume>362</volume>
          <fpage>17</fpage>
          <lpage>25</lpage>
        </citation>
        <citation citation-type="display-unstructured">O&#x2019;Kane EM, Stone TW (1998) Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur J Pharmacol 362:17&#x2013;25 <pub-id pub-id-type="pmid">9865525</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masino</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Diao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine A1 receptors</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2002</year>
          <volume>303</volume>
          <fpage>356</fpage>
          <lpage>363</lpage>
        </citation>
        <citation citation-type="display-unstructured">Masino SA, Diao L, Illes P et al (2002) Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine A1 receptors. J Pharmacol Exp Ther 303:356&#x2013;363 <pub-id pub-id-type="pmid">12235271</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Extracellular metabolism of nucleotides in the nervous system</article-title>
          <source>J Auton Pharmacol</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>397</fpage>
          <lpage>400</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H, Braun N (1996) Extracellular metabolism of nucleotides in the nervous system. J Auton Pharmacol 16:397&#x2013;400 <pub-id pub-id-type="pmid">9131425</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus</article-title>
          <source>J Neurosci</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>6286</fpage>
          <lpage>6295</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rodrigues RJ, Almeida T, Richardson PJ et al (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J Neurosci 25:6286&#x2013;6295 <pub-id pub-id-type="pmid">16000618</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendoza-Fernandez</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Barajas-Lopez</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2000</year>
          <volume>293</volume>
          <fpage>172</fpage>
          <lpage>179</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C (2000) ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. J Pharmacol Exp Ther 293:172&#x2013;179 <pub-id pub-id-type="pmid">10734167</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luthardt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borvendeg</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Sperlagh</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex</article-title>
          <source>Neurochem Int</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>161</fpage>
          <lpage>172</lpage>
        </citation>
        <citation citation-type="display-unstructured">Luthardt J, Borvendeg SJ, Sperlagh B et al (2003) P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex. Neurochem Int 42:161&#x2013;172 <pub-id pub-id-type="pmid">12421596</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coppi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Stephan</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices</article-title>
          <source>Purinergic Signalling</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>203</fpage>
        </citation>
        <citation citation-type="display-unstructured">Coppi E, Pugliese AM, Stephan H et al (2007) Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signalling 3:203 </citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kegel</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New insights into molecular structure and function of ectonucleotidases in the nervous system</article-title>
          <source>Neurochem Int</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>421</fpage>
          <lpage>425</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H, Braun N, Kegel B et al (1998) New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem Int 32:421&#x2013;425 <pub-id pub-id-type="pmid">9676740</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Extracellular metabolism of ATP and other nucleotides</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>2000</year>
          <volume>362</volume>
          <fpage>299</fpage>
          <lpage>309</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299&#x2013;309 <pub-id pub-id-type="pmid">11111825</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iqbal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vollmayer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDase) and the analysis of inhibitors by in-capillary enzymatic microreaction</article-title>
          <source>Purinergic Signalling</source>
          <year>2007</year>
          <volume>1</volume>
          <fpage>349</fpage>
          <lpage>358</lpage>
        </citation>
        <citation citation-type="display-unstructured">Iqbal J, Vollmayer P, Braun N et al (2007) A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDase) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signalling 1:349&#x2013;358 </citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kukulski</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Komoszynski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes</article-title>
          <source>Eur J Biochem</source>
          <year>2003</year>
          <volume>270</volume>
          <fpage>3447</fpage>
          <lpage>3454</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kukulski F, Komoszynski M (2003) Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes. Eur J Biochem 270:3447&#x2013;3454 <pub-id pub-id-type="pmid">12899702</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baqi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors</article-title>
          <source>Bioorg Med Chem Lett</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>5943</fpage>
          <lpage>5947</lpage>
        </citation>
        <citation citation-type="display-unstructured">Muller CE, Iqbal J, Baqi Y et al (2006) Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 16:5943&#x2013;5947 <pub-id pub-id-type="pmid">16997558</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wieraszko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seyfried</surname>
              <given-names>TN</given-names>
            </name>
          </person-group>
          <article-title>ATP-induced synaptic potentiation in hippocampal slices</article-title>
          <source>Brain Res</source>
          <year>1989</year>
          <volume>491</volume>
          <fpage>356</fpage>
          <lpage>359</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wieraszko A, Seyfried TN (1989) ATP-induced synaptic potentiation in hippocampal slices. Brain Res 491:356&#x2013;359 <pub-id pub-id-type="pmid">2765890</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Furuse</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mechanism of ATP-induced long-term potentiation involves extracellular phosphorylation of membrane proteins in guinea-pig hippocampal CA1 neurons</article-title>
          <source>Neurosci Lett</source>
          <year>1995</year>
          <volume>187</volume>
          <fpage>130</fpage>
          <lpage>132</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fujii S, Kato H, Furuse H et al (1995) The mechanism of ATP-induced long-term potentiation involves extracellular phosphorylation of membrane proteins in guinea-pig hippocampal CA1 neurons. Neurosci Lett 187:130&#x2013;132 <pub-id pub-id-type="pmid">7783959</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Extracellular adenosine 5&#x2032;-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices</article-title>
          <source>Neurosci Lett</source>
          <year>1999</year>
          <volume>276</volume>
          <fpage>21</fpage>
          <lpage>24</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fujii S, Kato H, Kuroda Y (1999) Extracellular adenosine 5&#x2032;-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices. Neurosci Lett 276:21&#x2013;24 <pub-id pub-id-type="pmid">10586965</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cooperativity between extracellular adenosine 5&#x2032;-triphosphate and activation of N-methyl-D-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>113</volume>
          <fpage>617</fpage>
          <lpage>628</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fujii S, Kato H, Kuroda Y (2002) Cooperativity between extracellular adenosine 5&#x2032;-triphosphate and activation of N-methyl-D-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons. Neuroscience 113:617&#x2013;628 <pub-id pub-id-type="pmid">12150781</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Kane</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Characterisation of ATP-induced facilitation of transmission in rat hippocampus</article-title>
          <source>Eur J Pharmacol</source>
          <year>2000</year>
          <volume>409</volume>
          <fpage>159</fpage>
          <lpage>166</lpage>
        </citation>
        <citation citation-type="display-unstructured">O&#x2019;Kane EM, Stone TW (2000) Characterisation of ATP-induced facilitation of transmission in rat hippocampus. Eur J Pharmacol 409:159&#x2013;166 <pub-id pub-id-type="pmid">11104829</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abrams</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Kandel</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Is contiguity detection in classical conditioning a system or a cellular property? Learning in Aplysia suggests a possible molecular site</article-title>
          <source>Trends Neurosci</source>
          <year>1988</year>
          <volume>11</volume>
          <fpage>128</fpage>
          <lpage>135</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abrams TW, Kandel ER (1988) Is contiguity detection in classical conditioning a system or a cellular property? Learning in Aplysia suggests a possible molecular site. Trends Neurosci 11:128&#x2013;135 <pub-id pub-id-type="pmid">2469180</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pankratov</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Miras-Portugal</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus</article-title>
          <source>Eur J Neurosci</source>
          <year>1998</year>
          <volume>10</volume>
          <fpage>3898</fpage>
          <lpage>3902</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pankratov Y, Castro E, Miras-Portugal MT et al (1998) A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. Eur J Neurosci 10:3898&#x2013;3902 <pub-id pub-id-type="pmid">9875366</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juranyi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sperlagh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vizi</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices</article-title>
          <source>Brain Res</source>
          <year>1999</year>
          <volume>823</volume>
          <fpage>183</fpage>
          <lpage>190</lpage>
        </citation>
        <citation citation-type="display-unstructured">Juranyi Z, Sperlagh B, Vizi ES (1999) Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 823:183&#x2013;190 <pub-id pub-id-type="pmid">10095025</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Turchi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vannucchi</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia</article-title>
          <source>Neurochem Int</source>
          <year>2005</year>
          <volume>47</volume>
          <fpage>442</fpage>
          <lpage>448</lpage>
        </citation>
        <citation citation-type="display-unstructured">Melani A, Turchi D, Vannucchi MG et al (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47:442&#x2013;448 <pub-id pub-id-type="pmid">16029911</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amadio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D&#x2019;Ambrosi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cavaliere</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2 receptor modulation and cytotoxic function in cultured CNS neurons</article-title>
          <source>Neuropharmacology</source>
          <year>2002</year>
          <volume>42</volume>
          <fpage>489</fpage>
          <lpage>501</lpage>
        </citation>
        <citation citation-type="display-unstructured">Amadio S, D&#x2019;Ambrosi N, Cavaliere F et al (2002) P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42:489&#x2013;501 <pub-id pub-id-type="pmid">11955520</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavaliere</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>D&#x2019;Ambrosi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ciotti</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists</article-title>
          <source>Neurochem Int</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>189</fpage>
          <lpage>197</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cavaliere F, D&#x2019;Ambrosi N, Ciotti MT et al (2001) Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem Int 38:189&#x2013;197 <pub-id pub-id-type="pmid">11099776</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Volonte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Merlo</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons</article-title>
          <source>J Neurosci Res</source>
          <year>1996</year>
          <volume>45</volume>
          <fpage>183</fpage>
          <lpage>193</lpage>
        </citation>
        <citation citation-type="display-unstructured">Volonte C, Merlo D (1996) Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons. J Neurosci Res 45:183&#x2013;193 <pub-id pub-id-type="pmid">8843035</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Volonte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ciotti</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>D&#x2019;Ambrosi</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones</article-title>
          <source>Neuropharmacology</source>
          <year>1999</year>
          <volume>38</volume>
          <fpage>1335</fpage>
          <lpage>1342</lpage>
        </citation>
        <citation citation-type="display-unstructured">Volonte C, Ciotti MT, D&#x2019;Ambrosi N et al (1999) Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 38:1335&#x2013;1342 <pub-id pub-id-type="pmid">10471087</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryu</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors</article-title>
          <source>Neuroreport</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1611</fpage>
          <lpage>1615</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ryu JK, Kim J, Choi SH et al (2002) ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13:1611&#x2013;1615 <pub-id pub-id-type="pmid">12352612</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kharlamov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Suramin reduces infarct volume in a model of focal brain ischemia in rats</article-title>
          <source>Exp Brain Res</source>
          <year>2002</year>
          <volume>147</volume>
          <fpage>353</fpage>
          <lpage>359</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kharlamov A, Jones SC, Kim DK (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp Brain Res 147:353&#x2013;359 <pub-id pub-id-type="pmid">12428143</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amadio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gianfriddo</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>974</fpage>
          <lpage>982</lpage>
        </citation>
        <citation citation-type="display-unstructured">Melani A, Amadio S, Gianfriddo M et al (2006) P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 26:974&#x2013;982 <pub-id pub-id-type="pmid">16395292</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lammer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gunther</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats</article-title>
          <source>Eur J Neurosci</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>2824</fpage>
          <lpage>2828</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lammer A, Gunther A, Beck A et al (2006) Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci 23:2824&#x2013;2828 <pub-id pub-id-type="pmid">16817887</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marrelli</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Khorovets</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>TD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion</article-title>
          <source>Am J Physiol</source>
          <year>1999</year>
          <volume>276</volume>
          <fpage>H33</fpage>
          <lpage>H41</lpage>
        </citation>
        <citation citation-type="display-unstructured">Marrelli SP, Khorovets A, Johnson TD et al (1999) P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol 276:H33&#x2013;H41 <pub-id pub-id-type="pmid">9887014</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lahiri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chaudhuri</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Chattopadhyay</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2005</year>
          <volume>34</volume>
          <fpage>248</fpage>
          <lpage>256</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lahiri P, Chaudhuri U, Chattopadhyay A et al (2005) Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events. Blood Cells Mol Dis 34:248&#x2013;256 <pub-id pub-id-type="pmid">15885609</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziegler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schillinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Funk</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease</article-title>
          <source>Stroke</source>
          <year>2005</year>
          <volume>36</volume>
          <fpage>1394</fpage>
          <lpage>1399</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ziegler S, Schillinger M, Funk M et al (2005) Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke 36:1394&#x2013;1399 <pub-id pub-id-type="pmid">15933261</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neary</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis</article-title>
          <source>J Auton Nerv Syst</source>
          <year>2000</year>
          <volume>81</volume>
          <fpage>200</fpage>
          <lpage>204</lpage>
        </citation>
        <citation citation-type="display-unstructured">Neary JT (2000) Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis. J Auton Nerv Syst 81:200&#x2013;204 <pub-id pub-id-type="pmid">10869721</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>DeForge</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Deluca</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Purinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications</article-title>
          <source>Med Hypotheses</source>
          <year>1992</year>
          <volume>37</volume>
          <fpage>213</fpage>
          <lpage>219</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rathbone MP, DeForge S, Deluca B et al (1992) Purinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications. Med Hypotheses 37:213&#x2013;219 <pub-id pub-id-type="pmid">1625596</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Involvement of P2 receptors in the growth and survival of neurons in the CNS</article-title>
          <source>Pharmacol Ther</source>
          <year>2006</year>
          <volume>109</volume>
          <fpage>297</fpage>
          <lpage>324</lpage>
        </citation>
        <citation citation-type="display-unstructured">Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109:297&#x2013;324 <pub-id pub-id-type="pmid">16102837</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mishrda</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation</article-title>
          <source>Development</source>
          <year>2006</year>
          <volume>133</volume>
          <fpage>675</fpage>
          <lpage>684</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mishrda SK, Braun N, Shukla V et al (2006) Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 133:675&#x2013;684 <pub-id pub-id-type="pmid">16436623</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuruma</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells</article-title>
          <source>Cell Calcium</source>
          <year>2006</year>
          <volume>39</volume>
          <fpage>313</fpage>
          <lpage>324</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kawano S, Otsu K, Kuruma A et al (2006) ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 39:313&#x2013;324 <pub-id pub-id-type="pmid">16445977</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="other">Coppi E, Pugliese AM, Urbani S et al (2007) ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 25:1840&#x2013;1849</citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="other">Scholzke MN, Schwaninger M (2007) Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia. J Mol Med 85:577&#x2013;588</citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Adenosine in the central nervous system: release mechanisms and extracellular concentrations</article-title>
          <source>J Neurochem</source>
          <year>2001</year>
          <volume>79</volume>
          <fpage>463</fpage>
          <lpage>484</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463&#x2013;484 <pub-id pub-id-type="pmid">11701750</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Bischofberger</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist</article-title>
          <source>Eur J Pharmacol</source>
          <year>1999</year>
          <volume>369</volume>
          <fpage>313</fpage>
          <lpage>317</lpage>
        </citation>
        <citation citation-type="display-unstructured">von Lubitz DK, Lin RC, Bischofberger N et al (1999) Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist. Eur J Pharmacol 369:313&#x2013;317 <pub-id pub-id-type="pmid">10225368</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yawo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chuhma</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors</article-title>
          <source>Nature</source>
          <year>1993</year>
          <volume>365</volume>
          <fpage>256</fpage>
          <lpage>258</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yawo H, Chuhma N (1993) Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature 365:256&#x2013;258 <pub-id pub-id-type="pmid">8396730</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Saggau</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus</article-title>
          <source>Neuron</source>
          <year>1994</year>
          <volume>12</volume>
          <fpage>1139</fpage>
          <lpage>1148</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wu LG, Saggau P (1994) Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139&#x2013;1148 <pub-id pub-id-type="pmid">8185949</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prince</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Adenosine decreases neurotransmitter release at central synapses</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>8586</fpage>
          <lpage>8590</lpage>
        </citation>
        <citation citation-type="display-unstructured">Prince DA, Stevens CF (1992) Adenosine decreases neurotransmitter release at central synapses. Proc Natl Acad Sci USA 89:8586&#x2013;8590 <pub-id pub-id-type="pmid">1382294</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>How does adenosine inhibit transmitter release?</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1988</year>
          <volume>9</volume>
          <fpage>130</fpage>
          <lpage>134</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fredholm BB, Dunwiddie TV (1988) How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130&#x2013;134 <pub-id pub-id-type="pmid">2907698</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burke</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Nadler</surname>
              <given-names>JV</given-names>
            </name>
          </person-group>
          <article-title>Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen</article-title>
          <source>J Neurochem</source>
          <year>1988</year>
          <volume>51</volume>
          <fpage>1541</fpage>
          <lpage>1551</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burke SP, Nadler JV (1988) Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J Neurochem 51:1541&#x2013;1551 <pub-id pub-id-type="pmid">2902197</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Moroni</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine decreases aspartate and glutamate release from rat hippocampal slices</article-title>
          <source>Eur J Pharmacol</source>
          <year>1984</year>
          <volume>104</volume>
          <fpage>19</fpage>
          <lpage>26</lpage>
        </citation>
        <citation citation-type="display-unstructured">Corradetti R, Lo CG, Moroni F et al (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 104:19&#x2013;26 <pub-id pub-id-type="pmid">6149943</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lupica</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Proctor</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording</article-title>
          <source>J Neurosci</source>
          <year>1992</year>
          <volume>12</volume>
          <fpage>3753</fpage>
          <lpage>3764</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lupica CR, Proctor WR, Dunwiddie TV (1992) Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording. J Neurosci 12:3753&#x2013;3764 <pub-id pub-id-type="pmid">1328558</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takigawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alzheimer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells</article-title>
          <source>J Physiol</source>
          <year>1999</year>
          <volume>517</volume>
          <issue>Pt 2</issue>
          <fpage>385</fpage>
          <lpage>390</lpage>
        </citation>
        <citation citation-type="display-unstructured">Takigawa T, Alzheimer C (1999) G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells. J Physiol 517(Pt 2):385&#x2013;390 <pub-id pub-id-type="pmid">10332089</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takigawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alzheimer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells</article-title>
          <source>J Physiol</source>
          <year>2002</year>
          <volume>539</volume>
          <fpage>67</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Takigawa T, Alzheimer C (2002) Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells. J Physiol 539:67&#x2013;75 <pub-id pub-id-type="pmid">11850502</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bordoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices</article-title>
          <source>Br J Pharmacol</source>
          <year>1999</year>
          <volume>128</volume>
          <fpage>1035</fpage>
          <lpage>1044</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Bordoni F, Corradetti R et al (1999) Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 128:1035&#x2013;1044 <pub-id pub-id-type="pmid">10556941</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bordoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices</article-title>
          <source>Br J Pharmacol</source>
          <year>1999</year>
          <volume>127</volume>
          <fpage>729</fpage>
          <lpage>739</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Bordoni F, Pedata F et al (1999) Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 127:729&#x2013;739 <pub-id pub-id-type="pmid">10401564</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Nicoll</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>14397</fpage>
          <lpage>14402</lpage>
        </citation>
        <citation citation-type="display-unstructured">Moore KA, Nicoll RA, Schmitz D (2003) Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 100:14397&#x2013;14402 <pub-id pub-id-type="pmid">14608033</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pepeu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Spignoli</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices</article-title>
          <source>Br J Pharmacol</source>
          <year>1984</year>
          <volume>83</volume>
          <fpage>69</fpage>
          <lpage>73</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pedata F, Pepeu G, Spignoli G (1984) Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices. Br J Pharmacol 83:69&#x2013;73 <pub-id pub-id-type="pmid">6487897</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pazzagli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pepeu</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system</article-title>
          <source>Gen Pharmacol</source>
          <year>1996</year>
          <volume>27</volume>
          <fpage>925</fpage>
          <lpage>933</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Pazzagli M, Pepeu G et al (1996) A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol 27:925&#x2013;933 <pub-id pub-id-type="pmid">8909972</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A2 receptor-mediated excitatory actions on the nervous system</article-title>
          <source>Prog Neurobiol</source>
          <year>1996</year>
          <volume>48</volume>
          <fpage>167</fpage>
          <lpage>189</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sebastiao AM, Ribeiro JA (1996) Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol 48:167&#x2013;189 <pub-id pub-id-type="pmid">8735876</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spignoli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pepeu</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A1 and A2 adenosine receptors modulate acetylcholine release from brain slices</article-title>
          <source>Eur J Pharmacol</source>
          <year>1984</year>
          <volume>97</volume>
          <fpage>341</fpage>
          <lpage>342</lpage>
        </citation>
        <citation citation-type="display-unstructured">Spignoli G, Pedata F, Pepeu G (1984) A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol 97:341&#x2013;342 <pub-id pub-id-type="pmid">6323196</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus</article-title>
          <source>Neurosci Lett</source>
          <year>1995</year>
          <volume>196</volume>
          <fpage>41</fpage>
          <lpage>44</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Johansson B, Fredholm BB et al (1995) Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci Lett 196:41&#x2013;44 <pub-id pub-id-type="pmid">7501252</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ploeg</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence for functionally important adenosine A2a receptors in the rat hippocampus</article-title>
          <source>Brain Res</source>
          <year>1994</year>
          <volume>649</volume>
          <fpage>208</fpage>
          <lpage>216</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Johansson B, van der Ploeg I et al (1994) Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res 649:208&#x2013;216 <pub-id pub-id-type="pmid">7953635</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Widdowson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum</article-title>
          <source>J Neurochem</source>
          <year>1997</year>
          <volume>69</volume>
          <fpage>315</fpage>
          <lpage>321</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dixon AK, Widdowson L, Richardson PJ (1997) Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J Neurochem 69:315&#x2013;321 <pub-id pub-id-type="pmid">9202325</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="other">Stone TW, Nikbakth M-R, O&#x2019;Kane EM (2004) Adenosine and purines. In: Riedel G, Platt B (eds) From messengers to molecules: memories are made of these. Kluwer Academic/Plenum, New York, p 196&#x2013;223</citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Betto</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reggio</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats</article-title>
          <source>Eur J Pharmacol</source>
          <year>1995</year>
          <volume>287</volume>
          <fpage>215</fpage>
          <lpage>217</lpage>
        </citation>
        <citation citation-type="display-unstructured">Popoli P, Betto P, Reggio R et al (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215&#x2013;217 <pub-id pub-id-type="pmid">8749040</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corsi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Striatal A<sub>2A</sub> adenosine receptor differentially regulate spontaneous and K<sup>+</sup>-evoked glutamate release in vivo in young and aged rats</article-title>
          <source>Neuroreport</source>
          <year>1999</year>
          <volume>10</volume>
          <fpage>687</fpage>
          <lpage>691</lpage>
        </citation>
        <citation citation-type="display-unstructured">Corsi C, Melani A, Bianchi L et al (1999) Striatal A2A adenosine receptor differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. Neuroreport 10:687&#x2013;691 <pub-id pub-id-type="pmid">10208531</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corsi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats</article-title>
          <source>Neuroreport</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>2591</fpage>
          <lpage>2595</lpage>
        </citation>
        <citation citation-type="display-unstructured">Corsi C, Melani A, Bianchi L et al (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11:2591&#x2013;2595 <pub-id pub-id-type="pmid">10943728</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Abbott</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Petrovitch</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of coffee and caffeine intake with the risk of Parkinson disease</article-title>
          <source>JAMA</source>
          <year>2000</year>
          <volume>283</volume>
          <fpage>2674</fpage>
          <lpage>2679</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ross GW, Abbott RD, Petrovitch H et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674&#x2013;2679 <pub-id pub-id-type="pmid">10819950</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ascherio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hernan</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective study of caffeine consumption and risk of Parkinson&#x2019;s disease in men and women</article-title>
          <source>Ann Neurol</source>
          <year>2001</year>
          <volume>50</volume>
          <fpage>56</fpage>
          <lpage>63</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ascherio A, Zhang SM, Hernan MA et al (2001) Prospective study of caffeine consumption and risk of Parkinson&#x2019;s disease in men and women. Ann Neurol 50:56&#x2013;63 <pub-id pub-id-type="pmid">11456310</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costenla</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>de Mendonca</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus</article-title>
          <source>Neurosci Lett</source>
          <year>2001</year>
          <volume>302</volume>
          <fpage>53</fpage>
          <lpage>57</lpage>
        </citation>
        <citation citation-type="display-unstructured">Costenla AR, Lopes LV, de Mendonca A et al (2001) A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci Lett 302:53&#x2013;57 <pub-id pub-id-type="pmid">11278110</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macek</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Schaffhauser</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Conn</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>6138</fpage>
          <lpage>6146</lpage>
        </citation>
        <citation citation-type="display-unstructured">Macek TA, Schaffhauser H, Conn PJ (1998) Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J Neurosci 18:6138&#x2013;6146 <pub-id pub-id-type="pmid">9698308</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleming</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Mogul</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway</article-title>
          <source>Neuropharmacology</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>353</fpage>
          <lpage>362</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fleming KM, Mogul DJ (1997) Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway. Neuropharmacology 36:353&#x2013;362 <pub-id pub-id-type="pmid">9175614</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laudadio</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Psarropoulou</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices</article-title>
          <source>Epilepsy Res</source>
          <year>2004</year>
          <volume>59</volume>
          <fpage>83</fpage>
          <lpage>94</lpage>
        </citation>
        <citation citation-type="display-unstructured">Laudadio MA, Psarropoulou C (2004) The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices. Epilepsy Res 59:83&#x2013;94 <pub-id pub-id-type="pmid">15246113</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etherington</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Frenguelli</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner</article-title>
          <source>Eur J Neurosci</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>2539</fpage>
          <lpage>2550</lpage>
        </citation>
        <citation citation-type="display-unstructured">Etherington LA, Frenguelli BG (2004) Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci 19:2539&#x2013;2550 <pub-id pub-id-type="pmid">15128407</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brand</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vissiennon</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Eschke</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons</article-title>
          <source>Neuropharmacology</source>
          <year>2001</year>
          <volume>40</volume>
          <fpage>85</fpage>
          <lpage>95</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brand A, Vissiennon Z, Eschke D et al (2001) Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40:85&#x2013;95 <pub-id pub-id-type="pmid">11077074</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors</article-title>
          <source>Br J Pharmacol</source>
          <year>2003</year>
          <volume>140</volume>
          <fpage>305</fpage>
          <lpage>314</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pugliese AM, Latini S, Corradetti R et al (2003) Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br J Pharmacol 140:305&#x2013;314 <pub-id pub-id-type="pmid">12970092</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pantoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Corsi</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage</article-title>
          <source>Stroke</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>2448</fpage>
          <lpage>2454</lpage>
        </citation>
        <citation citation-type="display-unstructured">Melani A, Pantoni L, Corsi C et al (1999) Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke 30:2448&#x2013;2454 <pub-id pub-id-type="pmid">10548683</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pantoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bordoni</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat</article-title>
          <source>Brain Res</source>
          <year>2003</year>
          <volume>959</volume>
          <fpage>243</fpage>
          <lpage>250</lpage>
        </citation>
        <citation citation-type="display-unstructured">Melani A, Pantoni L, Bordoni F et al (2003) The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 959:243&#x2013;250 <pub-id pub-id-type="pmid">12493612</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bordoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions</article-title>
          <source>Brain Res</source>
          <year>1998</year>
          <volume>794</volume>
          <fpage>325</fpage>
          <lpage>328</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Bordoni F, Corradetti R et al (1998) Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res 794:325&#x2013;328 <pub-id pub-id-type="pmid">9622666</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Damian</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lynas</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro</article-title>
          <source>J Neurochem</source>
          <year>2006</year>
          <volume>97</volume>
          <fpage>1357</fpage>
          <lpage>1368</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pearson T, Damian K, Lynas RE et al (2006) Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro. J Neurochem 97:1357&#x2013;1368 <pub-id pub-id-type="pmid">16696848</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dux</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fastbom</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ungerstedt</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus</article-title>
          <source>Brain Res</source>
          <year>1990</year>
          <volume>516</volume>
          <fpage>248</fpage>
          <lpage>256</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dux E, Fastbom J, Ungerstedt U et al (1990) Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516:248&#x2013;256 <pub-id pub-id-type="pmid">2364291</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Smith-Barbour</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion</article-title>
          <source>Neurochem Res</source>
          <year>1994</year>
          <volume>19</volume>
          <fpage>1125</fpage>
          <lpage>1130</lpage>
        </citation>
        <citation citation-type="display-unstructured">Phillis JW, Smith-Barbour M, O&#x2019;Regan MH et al (1994) Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem Res 19:1125&#x2013;1130 <pub-id pub-id-type="pmid">7824064</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frenguelli</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Wigmore</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Llaudet</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus</article-title>
          <source>J Neurochem</source>
          <year>2007</year>
          <volume>101</volume>
          <fpage>1400</fpage>
          <lpage>1413</lpage>
        </citation>
        <citation citation-type="display-unstructured">Frenguelli BG, Wigmore G, Llaudet E et al (2007) Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J Neurochem 101:1400&#x2013;1413 <pub-id pub-id-type="pmid">17459147</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Deoxycoformycin antagonizes ischemia-induced neuronal degeneration</article-title>
          <source>Brain Res Bull</source>
          <year>1989</year>
          <volume>22</volume>
          <fpage>537</fpage>
          <lpage>540</lpage>
        </citation>
        <citation citation-type="display-unstructured">Phillis JW, O&#x2019;Regan MH (1989) Deoxycoformycin antagonizes ischemia-induced neuronal degeneration. Brain Res Bull 22:537&#x2013;540 <pub-id pub-id-type="pmid">2785431</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat</article-title>
          <source>Brain Res</source>
          <year>1992</year>
          <volume>571</volume>
          <fpage>272</fpage>
          <lpage>280</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lin Y, Phillis JW (1992) Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat. Brain Res 571:272&#x2013;280 <pub-id pub-id-type="pmid">1611498</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeLeo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kreutzberg</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Protection against ischemic brain damage using propentofylline in gerbils</article-title>
          <source>Stroke</source>
          <year>1988</year>
          <volume>19</volume>
          <fpage>1535</fpage>
          <lpage>1539</lpage>
        </citation>
        <citation citation-type="display-unstructured">DeLeo J, Schubert P, Kreutzberg GW (1988) Protection against ischemic brain damage using propentofylline in gerbils. Stroke 19:1535&#x2013;1539 <pub-id pub-id-type="pmid">3201513</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parkinson</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zamzow</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Astrocytes and neurons: different roles in regulating adenosine levels</article-title>
          <source>Neurol Res</source>
          <year>2005</year>
          <volume>27</volume>
          <fpage>153</fpage>
          <lpage>160</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parkinson FE, Xiong W, Zamzow CR (2005) Astrocytes and neurons: different roles in regulating adenosine levels. Neurol Res 27:153&#x2013;160 <pub-id pub-id-type="pmid">15829178</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats</article-title>
          <source>Neurol Res</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>317</fpage>
          <lpage>323</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kitagawa H, Mori A, Shimada J et al (2002) Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats. Neurol Res 24:317&#x2013;323 <pub-id pub-id-type="pmid">11958429</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions</article-title>
          <source>J Neurochem</source>
          <year>1993</year>
          <volume>61</volume>
          <fpage>284</fpage>
          <lpage>289</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pedata F, Latini S, Pugliese AM et al (1993) Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem 61:284&#x2013;289 <pub-id pub-id-type="pmid">8515275</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists</article-title>
          <source>Stroke</source>
          <year>1990</year>
          <volume>21</volume>
          <fpage>III20</fpage>
          <lpage>III22</lpage>
        </citation>
        <citation citation-type="display-unstructured">Choi DW (1990) Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke 21:III20&#x2013;III22 <pub-id pub-id-type="pmid">2146778</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greene</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>The electrophysiology of adenosine in the mammalian central nervous system</article-title>
          <source>Prog Neurobiol</source>
          <year>1991</year>
          <volume>36</volume>
          <fpage>329</fpage>
          <lpage>341</lpage>
        </citation>
        <citation citation-type="display-unstructured">Greene RW, Haas HL (1991) The electrophysiology of adenosine in the mammalian central nervous system. Prog Neurobiol 36:329&#x2013;341 <pub-id pub-id-type="pmid">1678539</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tominaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices</article-title>
          <source>Neurosci Lett</source>
          <year>1992</year>
          <volume>145</volume>
          <fpage>67</fpage>
          <lpage>70</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tominaga K, Shibata S, Watanabe S (1992) A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices. Neurosci Lett 145:67&#x2013;70 <pub-id pub-id-type="pmid">1461571</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gourine</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gourine</surname>
              <given-names>VN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fever in systemic inflammation: roles of purines</article-title>
          <source>Front Biosci</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>1011</fpage>
          <lpage>1022</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gourine AV, Dale N, Gourine VN et al (2004) Fever in systemic inflammation: roles of purines. Front Biosci 9:1011&#x2013;1022 <pub-id pub-id-type="pmid">14766427</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Adenosine in the treatment of stroke: yes, maybe, or absolutely not?</article-title>
          <source>Expert Opin Invest Drugs</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>619</fpage>
          <lpage>632</lpage>
        </citation>
        <citation citation-type="display-unstructured">von Lubitz DK (2001) Adenosine in the treatment of stroke: yes, maybe, or absolutely not? Expert Opin Invest Drugs 10:619&#x2013;632 </citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Currie</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Etherington</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Plasticity of purine release during cerebral ischemia: clinical implications?</article-title>
          <source>J Cell Mol Med</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>362</fpage>
          <lpage>375</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pearson T, Currie AJ, Etherington LA et al (2003) Plasticity of purine release during cerebral ischemia: clinical implications? J Cell Mol Med 7:362&#x2013;375 <pub-id pub-id-type="pmid">14754505</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarrott</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Domer</surname>
              <given-names>FR</given-names>
            </name>
          </person-group>
          <article-title>A gerbil model of cerebral ischemia suitable for drug evaluation</article-title>
          <source>Stroke</source>
          <year>1980</year>
          <volume>11</volume>
          <fpage>203</fpage>
          <lpage>209</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jarrott DM, Domer FR (1980) A gerbil model of cerebral ischemia suitable for drug evaluation. Stroke 11:203&#x2013;209 <pub-id pub-id-type="pmid">6989034</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rudolphi</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Keil</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fastbom</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment</article-title>
          <source>Neurosci Lett</source>
          <year>1989</year>
          <volume>103</volume>
          <fpage>275</fpage>
          <lpage>280</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rudolphi KA, Keil M, Fastbom J et al (1989) Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Lett 103:275&#x2013;280 <pub-id pub-id-type="pmid">2812514</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>JW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine receptor ligands: differences with acute versus chronic treatment</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1996</year>
          <volume>17</volume>
          <fpage>108</fpage>
          <lpage>113</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jacobson KA, von Lubitz DK, Daly JW et al (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108&#x2013;113 <pub-id pub-id-type="pmid">8936347</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Purinergic drugs: opportunities in the 1990s</article-title>
          <source>Drug Dev Res</source>
          <year>1993</year>
          <volume>28</volume>
          <fpage>438</fpage>
        </citation>
        <citation citation-type="display-unstructured">Williams M (1993) Purinergic drugs: opportunities in the 1990s. Drug Dev Res 28:438 </citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>IA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils</article-title>
          <source>Eur J Pharmacol</source>
          <year>1996</year>
          <volume>316</volume>
          <fpage>171</fpage>
          <lpage>179</lpage>
        </citation>
        <citation citation-type="display-unstructured">von Lubitz DK, Lin RC, Paul IA et al (1996) Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils. Eur J Pharmacol 316:171&#x2013;179 <pub-id pub-id-type="pmid">8982684</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Goshgarian</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>Adenosine and neurotrauma: therapeutic perspectives</article-title>
          <source>Neurol Res</source>
          <year>2001</year>
          <volume>23</volume>
          <fpage>183</fpage>
          <lpage>189</lpage>
        </citation>
        <citation citation-type="display-unstructured">Phillis JW, Goshgarian HG (2001) Adenosine and neurotrauma: therapeutic perspectives. Neurol Res 23:183&#x2013;189 <pub-id pub-id-type="pmid">11320597</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil</article-title>
          <source>Life Sci</source>
          <year>1994</year>
          <volume>55</volume>
          <fpage>L61</fpage>
          <lpage>L65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gao Y, Phillis JW (1994) CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 55:L61&#x2013;L65 </citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bona</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Aden</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gilland</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists</article-title>
          <source>Neuropharmacology</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>1327</fpage>
          <lpage>1338</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bona E, Aden U, Gilland E et al (1997) Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology 36:1327&#x2013;1338 <pub-id pub-id-type="pmid">9364488</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monopoli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lozza</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Forlani</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats</article-title>
          <source>Neuroreport</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>3955</fpage>
          <lpage>3959</lpage>
        </citation>
        <citation citation-type="display-unstructured">Monopoli A, Lozza G, Forlani A et al (1998) Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport 9:3955&#x2013;3959 <pub-id pub-id-type="pmid">9875735</pub-id></citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gianfriddo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Turchi</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The protective effect of adenosine A2A receptor antagonism in cerebral ischemia</article-title>
          <source>Neurol Res</source>
          <year>2005</year>
          <volume>27</volume>
          <fpage>169</fpage>
          <lpage>174</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pedata F, Gianfriddo M, Turchi D et al (2005) The protective effect of adenosine A2A receptor antagonism in cerebral ischemia. Neurol Res 27:169&#x2013;174 <pub-id pub-id-type="pmid">15829180</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gianfriddo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vannucchi</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia</article-title>
          <source>Brain Res</source>
          <year>2006</year>
          <volume>1073&#x2013;1074</volume>
          <fpage>470</fpage>
          <lpage>480</lpage>
        </citation>
        <citation citation-type="display-unstructured">Melani A, Gianfriddo M, Vannucchi MG et al (2006) The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res 1073&#x2013;1074:470&#x2013;480 <pub-id pub-id-type="pmid">16443200</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice</article-title>
          <source>J Neurosci</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>9192</fpage>
          <lpage>9200</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen JF, Huang Z, Ma J et al (1999) A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19:9192&#x2013;9200 <pub-id pub-id-type="pmid">10531422</pub-id></citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcoli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Raiteri</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bonfanti</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices</article-title>
          <source>Neuropharmacology</source>
          <year>2003</year>
          <volume>45</volume>
          <fpage>201</fpage>
          <lpage>210</lpage>
        </citation>
        <citation citation-type="display-unstructured">Marcoli M, Raiteri L, Bonfanti A et al (2003) Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacology 45:201&#x2013;210 <pub-id pub-id-type="pmid">12842126</pub-id></citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex</article-title>
          <source>Neurosci Lett</source>
          <year>1992</year>
          <volume>138</volume>
          <fpage>169</fpage>
          <lpage>172</lpage>
        </citation>
        <citation citation-type="display-unstructured">O&#x2019;Regan MH, Simpson RE, Perkins LM et al (1992) The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 138:169&#x2013;172 <pub-id pub-id-type="pmid">1357597</pub-id></citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists</article-title>
          <source>J Neurochem</source>
          <year>1992</year>
          <volume>58</volume>
          <fpage>1683</fpage>
          <lpage>1690</lpage>
        </citation>
        <citation citation-type="display-unstructured">Simpson RE, O&#x2019;Regan MH, Perkins LM et al (1992) Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J Neurochem 58:1683&#x2013;1690 <pub-id pub-id-type="pmid">1348522</pub-id></citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiebich</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Biber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lieb</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2A-receptors</article-title>
          <source>Glia</source>
          <year>1996</year>
          <volume>18</volume>
          <fpage>152</fpage>
          <lpage>160</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fiebich BL, Biber K, Lieb K et al (1996) Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2A-receptors. Glia 18:152&#x2013;160 <pub-id pub-id-type="pmid">8913778</pub-id></citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saura</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Angulo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ejarque</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia</article-title>
          <source>J Neurochem</source>
          <year>2005</year>
          <volume>95</volume>
          <fpage>919</fpage>
          <lpage>929</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saura J, Angulo E, Ejarque A et al (2005) Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 95:919&#x2013;929 <pub-id pub-id-type="pmid">16092928</pub-id></citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>CN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system</article-title>
          <source>Eur J Neurosci</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>1786</fpage>
          <lpage>1796</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lee YC, Chien CL, Sun CN et al (2003) Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur J Neurosci 18:1786&#x2013;1796 <pub-id pub-id-type="pmid">14622213</pub-id></citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishizaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new neuromodulatory pathway with a glial contribution mediated via A2A adenosine receptors</article-title>
          <source>Glia</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>133</fpage>
          <lpage>147</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nishizaki T, Nagai K, Nomura T et al (2002) A new neuromodulatory pathway with a glial contribution mediated via A2A adenosine receptors. Glia 39:133&#x2013;147 <pub-id pub-id-type="pmid">12112365</pub-id></citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pintor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Galluzzo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grieco</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors</article-title>
          <source>J Neurochem</source>
          <year>2004</year>
          <volume>89</volume>
          <fpage>152</fpage>
          <lpage>156</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pintor A, Galluzzo M, Grieco R et al (2004) Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J Neurochem 89:152&#x2013;156 <pub-id pub-id-type="pmid">15030399</pub-id></citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Irving</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Barone</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Reith</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat</article-title>
          <source>Brain Res Mol Brain Res</source>
          <year>2000</year>
          <volume>77</volume>
          <fpage>65</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Irving EA, Barone FC, Reith AD et al (2000) Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 77:65&#x2013;75 <pub-id pub-id-type="pmid">10814833</pub-id></citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Che</surname>
              <given-names>XM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>1320</fpage>
          <lpage>1330</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wu DC, Ye W, Che XM et al (2000) Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 20:1320&#x2013;1330 <pub-id pub-id-type="pmid">10994854</pub-id></citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barone</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Irving</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia</article-title>
          <source>Med Res Rev</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>129</fpage>
          <lpage>145</lpage>
        </citation>
        <citation citation-type="display-unstructured">Barone FC, Irving EA, Ray AM et al (2001) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 21:129&#x2013;145 <pub-id pub-id-type="pmid">11223862</pub-id></citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Signore</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>694</fpage>
          <lpage>712</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gao Y, Signore AP, Yin W et al (2005) Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 25:694&#x2013;712 <pub-id pub-id-type="pmid">15716857</pub-id></citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morooka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimohama</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>18518</fpage>
          <lpage>18521</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kawasaki H, Morooka T, Shimohama S et al (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272:18518&#x2013;18521 <pub-id pub-id-type="pmid">9228012</pub-id></citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <citation citation-type="other">Trincavelli ML, Melani A, Guidi S et al (2007) Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem. DOI 10.1111/j.1471-4159.2007.04990.x</citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Mariani</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury</article-title>
          <source>Nat Med</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>1081</fpage>
          <lpage>1087</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yu L, Huang Z, Mariani J et al (2004) Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med 10:1081&#x2013;1087 <pub-id pub-id-type="pmid">15448683</pub-id></citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheardown</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Knutsen</surname>
              <given-names>LJS</given-names>
            </name>
          </person-group>
          <article-title>Unexpected neuroprotection observed with the adenosine A2A receptor agonist cgs 21680</article-title>
          <source>Drug Dev Res</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>108</fpage>
        </citation>
        <citation citation-type="display-unstructured">Sheardown MJ, Knutsen LJS (1996) Unexpected neuroprotection observed with the adenosine A2A receptor agonist cgs 21680. Drug Dev Res 39:108 </citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist</article-title>
          <source>Eur J Pharmacol</source>
          <year>1995</year>
          <volume>287</volume>
          <fpage>295</fpage>
          <lpage>302</lpage>
        </citation>
        <citation citation-type="display-unstructured">von Lubitz DK, Lin RC, Jacobson KA (1995) Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. Eur J Pharmacol 287:295&#x2013;302 <pub-id pub-id-type="pmid">8991804</pub-id></citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists</article-title>
          <source>Neuroscience</source>
          <year>1998</year>
          <volume>85</volume>
          <fpage>229</fpage>
          <lpage>237</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jones PA, Smith RA, Stone TW (1998) Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience 85:229&#x2013;237 <pub-id pub-id-type="pmid">9607714</pub-id></citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist</article-title>
          <source>Brain Res</source>
          <year>1998</year>
          <volume>800</volume>
          <fpage>328</fpage>
          <lpage>335</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jones PA, Smith RA, Stone TW (1998) Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res 800:328&#x2013;335 <pub-id pub-id-type="pmid">9685693</pub-id></citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sitkovsky</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The &#x2018;danger&#x2019; sensors that STOP the immune response: the A2 adenosine receptors?</article-title>
          <source>Trends Immunol</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>299</fpage>
          <lpage>304</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sitkovsky MV, Ohta A (2005) The &#x2018;danger&#x2019; sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26:299&#x2013;304 <pub-id pub-id-type="pmid">15922945</pub-id></citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayne</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fotheringham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage</article-title>
          <source>Ann Neurol</source>
          <year>2001</year>
          <volume>49</volume>
          <fpage>727</fpage>
          <lpage>735</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mayne M, Fotheringham J, Yan HJ et al (2001) Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol 49:727&#x2013;735 <pub-id pub-id-type="pmid">11409424</pub-id></citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Corsi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The source of brain adenosine outflow during ischemia and electrical stimulation</article-title>
          <source>Neurochem Int</source>
          <year>1995</year>
          <volume>27</volume>
          <fpage>239</fpage>
          <lpage>244</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Corsi C, Pedata F et al (1995) The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem Int 27:239&#x2013;244 <pub-id pub-id-type="pmid">8520462</pub-id></citation>
      </ref>
      <ref id="CR135">
        <label>135.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Coppi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spalluto</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro</article-title>
          <source>Br J Pharmacol</source>
          <year>2006</year>
          <volume>147</volume>
          <fpage>524</fpage>
          <lpage>532</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pugliese AM, Coppi E, Spalluto G et al (2006) A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro. Br J Pharmacol 147:524&#x2013;532 <pub-id pub-id-type="pmid">16415905</pub-id></citation>
      </ref>
      <ref id="CR136">
        <label>136.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Popik</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine A3 receptor stimulation and cerebral ischemia</article-title>
          <source>Eur J Pharmacol</source>
          <year>1994</year>
          <volume>263</volume>
          <fpage>59</fpage>
          <lpage>67</lpage>
        </citation>
        <citation citation-type="display-unstructured">von Lubitz DK, Lin RC, Popik P et al (1994) Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59&#x2013;67 <pub-id pub-id-type="pmid">7821362</pub-id></citation>
      </ref>
      <ref id="CR137">
        <label>137.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Benovic</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Stiles</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>29607</fpage>
          <lpage>29613</lpage>
        </citation>
        <citation citation-type="display-unstructured">Palmer TM, Benovic JL, Stiles GL (1995) Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism. J Biol Chem 270:29607&#x2013;29613 <pub-id pub-id-type="pmid">7494005</pub-id></citation>
      </ref>
      <ref id="CR138">
        <label>138.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trincavelli</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Tuscano</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marroni</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation</article-title>
          <source>Mol Pharmacol</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>1373</fpage>
          <lpage>1384</lpage>
        </citation>
        <citation citation-type="display-unstructured">Trincavelli ML, Tuscano D, Marroni M et al (2002) A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol 62:1373&#x2013;1384 <pub-id pub-id-type="pmid">12435805</pub-id></citation>
      </ref>
      <ref id="CR139">
        <label>139.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hentschel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lewerenz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons</article-title>
          <source>Restor Neurol Neurosci</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>55</fpage>
          <lpage>63</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hentschel S, Lewerenz A, Nieber K (2003) Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 21:55&#x2013;63 <pub-id pub-id-type="pmid">12808203</pub-id></citation>
      </ref>
      <ref id="CR140">
        <label>140.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fedorova</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Basile</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration</article-title>
          <source>Cell Mol Neurobiol</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>431</fpage>
          <lpage>447</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fedorova IM, Jacobson MA, Basile A et al (2003) Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol 23:431&#x2013;447 <pub-id pub-id-type="pmid">12825837</pub-id></citation>
      </ref>
      <ref id="CR141">
        <label>141.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of adenosine A3 receptors reduces ischemic brain injury in rodents</article-title>
          <source>J Neurosci Res</source>
          <year>2006</year>
          <volume>84</volume>
          <fpage>1848</fpage>
          <lpage>1855</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen GJ, Harvey BK, Shen H et al (2006) Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84:1848&#x2013;1855 <pub-id pub-id-type="pmid">17016854</pub-id></citation>
      </ref>
      <ref id="CR142">
        <label>142.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Coppi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine in the central nervous system: effects on neurotransmission and neuroprotection</article-title>
          <source>Immunol Endocr Metab Agents Med Chem</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>304</fpage>
          <lpage>321</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pedata F, Pugliese AM, Coppi E et al (2007) Adenosine in the central nervous system: effects on neurotransmission and neuroprotection. Immunol Endocr Metab Agents Med Chem 7:304&#x2013;321 </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>